Search - tctmd.com

Displaying 541 - 560 of 1230

Sort: Relevancy | Date

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

Todd Neale

November 14, 2020

News Opinion CV Team Dispatch

November 2020 News Roundup

L.A. McKeown

November 01, 2020

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

Caitlin E. Cox

October 29, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Daily News

As Cardiac Procedures Plummet, Concerns Mount for COVID-19’s Collateral Damage

Shelley Wood

October 22, 2020

News Conference News TCT 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

L.A. McKeown

October 21, 2020

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Presenter: Philippe Genereux

October 16, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Presenter: Michael Reardon

October 16, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

Presenter: Martin Leon

October 16, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

Presentation TCT 2020

TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

Presenter: Jaffar Khan

October 14, 2020

Presentation TCT 2020

TCT 147: Limitations of Established Cardiac Biomarkers in Low- to Intermediate-Risk TF-TAVR Patients With Advanced CKD

Presenter: Hatim Seoudy

October 14, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

Advertisement

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

November 2020 News Roundup

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

As Cardiac Procedures Plummet, Concerns Mount for COVID-19’s Collateral Damage

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

TCT 147: Limitations of Established Cardiac Biomarkers in Low- to Intermediate-Risk TF-TAVR Patients With Advanced CKD

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content